Tasca C, Zuccarini M, Di Iorio P, Ciruela F
Purinergic Signal. 2024; .
PMID: 39004650
DOI: 10.1007/s11302-024-10033-y.
Weese-Myers M, Cryan M, Witt C, Caldwell K, Modi B, Ross A
ACS Chem Neurosci. 2023; 14(9):1646-1658.
PMID: 37040534
PMC: 10265669.
DOI: 10.1021/acschemneuro.3c00048.
Birder L, Jackson E
Nat Rev Urol. 2022; 19(11):681-687.
PMID: 36071153
PMC: 9842101.
DOI: 10.1038/s41585-022-00642-w.
Nguyen H, Ho Thi L, Ho X, Cao V, Le Hoang D
Biomedicine (Taipei). 2022; 12(1):39-52.
PMID: 35836917
PMC: 9236712.
DOI: 10.37796/2211-8039.1243.
Van Breedam E, Ponsaerts P
Int J Mol Sci. 2022; 23(13).
PMID: 35806146
PMC: 9266337.
DOI: 10.3390/ijms23137140.
Luminescent Human iPSC-Derived Neurospheroids Enable Modeling of Neurotoxicity After Oxygen-glucose Deprivation.
Van Breedam E, Nijak A, Buyle-Huybrecht T, Di Stefano J, Boeren M, Govaerts J
Neurotherapeutics. 2022; 19(2):550-569.
PMID: 35289376
PMC: 9226265.
DOI: 10.1007/s13311-022-01212-z.
Neuroprotective Effects of Guanosine in Ischemic Stroke-Small Steps towards Effective Therapy.
Chojnowski K, Opielka M, Nazar W, Kowianski P, Smolenski R
Int J Mol Sci. 2021; 22(13).
PMID: 34199004
PMC: 8268871.
DOI: 10.3390/ijms22136898.
Guanosine Neuroprotective Action in Hippocampal Slices Subjected to Oxygen and Glucose Deprivation Restores ATP Levels, Lactate Release and Glutamate Uptake Impairment: Involvement of Nitric Oxide.
Thomaz D, Andreguetti R, Binder L, da Luz Scheffer D, Correa A, Silva F
Neurochem Res. 2020; 45(9):2217-2229.
PMID: 32666283
DOI: 10.1007/s11064-020-03083-2.
miR-9 Upregulation Integrates Post-ischemic Neuronal Survival and Regeneration In Vitro.
Nampoothiri S, Rajanikant G
Cell Mol Neurobiol. 2018; 39(2):223-240.
PMID: 30539420
PMC: 11469860.
DOI: 10.1007/s10571-018-0642-1.
Neuromodulatory Effects of Guanine-Based Purines in Health and Disease.
Tasca C, Lanznaster D, Oliveira K, Fernandez-Duenas V, Ciruela F
Front Cell Neurosci. 2018; 12:376.
PMID: 30459558
PMC: 6232889.
DOI: 10.3389/fncel.2018.00376.
Metabolomic changes in the mouse retina after optic nerve injury.
Sato K, Saigusa D, Saito R, Fujioka A, Nakagawa Y, Nishiguchi K
Sci Rep. 2018; 8(1):11930.
PMID: 30093719
PMC: 6085332.
DOI: 10.1038/s41598-018-30464-z.
Neuroprotective Effects of Guanosine Administration on In Vivo Cortical Focal Ischemia in Female and Male Wistar Rats.
Teixeira L, Almeida R, Rohden F, Martins L, Spritzer P, de Souza D
Neurochem Res. 2018; 43(7):1476-1489.
PMID: 29855847
DOI: 10.1007/s11064-018-2562-3.
Delayed administration of guanosine improves long‑term functional recovery and enhances neurogenesis and angiogenesis in a mouse model of photothrombotic stroke.
Deng G, Qiu Z, Li D, Fang Y, Zhang S
Mol Med Rep. 2017; 15(6):3999-4004.
PMID: 28487988
PMC: 5436205.
DOI: 10.3892/mmr.2017.6521.
Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders.
Lanznaster D, Dal-Cim T, Piermartiri T, Tasca C
Aging Dis. 2016; 7(5):657-679.
PMID: 27699087
PMC: 5036959.
DOI: 10.14336/AD.2016.0208.
Guanosine prevents nitroxidative stress and recovers mitochondrial membrane potential disruption in hippocampal slices subjected to oxygen/glucose deprivation.
Thomaz D, Dal-Cim T, Martins W, Cunha M, Lanznaster D, Bem A
Purinergic Signal. 2016; 12(4):707-718.
PMID: 27613537
PMC: 5124011.
DOI: 10.1007/s11302-016-9534-3.
Anti-aging effects of guanosine in glial cells.
Souza D, Bellaver B, Bobermin L, Souza D, Quincozes-Santos A
Purinergic Signal. 2016; 12(4):697-706.
PMID: 27585449
PMC: 5124010.
DOI: 10.1007/s11302-016-9533-4.
The Guanine-Based Purinergic System: The Tale of An Orphan Neuromodulation.
Di Liberto V, Mudo G, Garozzo R, Frinchi M, Fernandez-Duenas V, Di Iorio P
Front Pharmacol. 2016; 7:158.
PMID: 27378923
PMC: 4911385.
DOI: 10.3389/fphar.2016.00158.
Guanosine and its role in neuropathologies.
Bettio L, Gil-Mohapel J, Rodrigues A
Purinergic Signal. 2016; 12(3):411-26.
PMID: 27002712
PMC: 5023624.
DOI: 10.1007/s11302-016-9509-4.
Neuroprotection Promoted by Guanosine Depends on Glutamine Synthetase and Glutamate Transporters Activity in Hippocampal Slices Subjected to Oxygen/Glucose Deprivation.
Dal-Cim T, Martins W, Thomaz D, Coelho V, Poluceno G, Lanznaster D
Neurotox Res. 2016; 29(4):460-8.
PMID: 26858177
DOI: 10.1007/s12640-015-9595-z.
Intranasal guanosine administration presents a wide therapeutic time window to reduce brain damage induced by permanent ischemia in rats.
Ramos D, Muller G, Rocha G, Hirata Dellavia G, Almeida R, Pettenuzzo L
Purinergic Signal. 2015; 12(1):149-59.
PMID: 26695181
PMC: 4749534.
DOI: 10.1007/s11302-015-9489-9.